John Raymond Murphy - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Cadrenal Therapeutics, Inc. (CVKD)

Filing Manager: MURPHY JOHN RAYMOND
Reporting Manager: John Raymond Murphy
Security: Cadrenal Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol: CVKD
Shares outstanding: 1.8M shares
Disclosed Ownership: 53.2K shares
Ownership: 2.96%
Form type: SCHEDULE 13G/A
Date filed: 1/15/2025, 04:23 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
John Raymond Murphy	2.96%	53.2K	53.2K	0	/s/ John Raymond Murphy	John Raymond Murphy